CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $9.35M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +4 vs. previous quarter
- 31
- 13F valueReported value at the end of Q2 2026
- $8.39M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$29.6M
- No comparable prior period
- Free cash flow, FY2025
- -$21.2M
- No comparable prior period
- Revenue, Q2 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 171.4K
- Shares sold short
- Change
- +109.7K
- +178.0% vs. previous
- Days to cover
- 1.78
- At average daily volume
Superinvestors holding CALC, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding CALC at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by CalciMedica, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 (view filing) | Jun 25 | 4 days | Middleton Fred ADirector, 10% Owner | PPurchase | +249.0K | $0.80 | +$199.2K | +30.6%1.06M after | |
| Sep 22, 2025 (view filing) | Sep 18 | 4 days | Roberts Eric WCHIEF BUSINESS OFFICER | PPurchase | +2.50K | $3.07 | +$7.67K | +3.1%84.2K after | |
| Sep 17, 2025 (view filing) | Sep 15 | 2 days | Roberts Eric WCHIEF BUSINESS OFFICER | PPurchase | +3.40K | $2.68 | +$9.11K | +4.3%81.7K after | |
| Sep 15, 2025 (view filing) | Sep 12 | 3 days | Roberts Eric WCHIEF BUSINESS OFFICER | PPurchase | +5.00K | $3.12 | +$15.6K | +6.8%78.3K after | |
| Sep 11, 2025 (view filing) | Sep 9 | 2 days | Roberts Eric WCHIEF BUSINESS OFFICER | PPurchase | +2.34K | $3.15 | +$7.38K | +3.3%73.3K after | |
| Sep 2, 2025 (view filing) | Aug 28-29 | 5 days | Roberts Eric WCHIEF BUSINESS OFFICER | PPurchase | +10.0K | $2.85 | +$28.5K | +16.4%70.9K after | 2 lots |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Roberts Eric WCHIEF BUSINESS OFFICER | PPurchase | +3.51K | $2.79 | +$9.79K | +6.1%60.9K after | |
| Aug 21, 2025 (view filing) | Aug 19-20 | 2 days | Roberts Eric WCHIEF BUSINESS OFFICER | PPurchase | +3.00K | $2.74 | +$8.23K | +5.5%57.4K after | 2 lots |
| Aug 21, 2025 (view filing) | Aug 19 | 2 days | Hebbar SudarshanChief Medical Officer | PPurchase | +9.56K | $2.82 | +$27.0K | +18.4%61.5K after | |
| Aug 19, 2025 (view filing) | Aug 15 | 4 days | Roberts Eric WCHIEF BUSINESS OFFICER | PPurchase | +5.08K | $2.90 | +$14.7K | +10.3%54.4K after |
Top 10 13F holders, Q2 2026
See all 31 holdersThe largest institutional positions in CalciMedica, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodline Partners LP | 2,489,729 | $2.56M | 0.01% | +2,489,729 | New |
| Heights Capital Management, Inc | 1,556,081 | $1.60M | 0.37% | +1,556,081 | New |
| Squadron Capital Management LLC | 1,244,864 | $1.28M | 0.44% | +1,244,864 | New |
| StemPoint Capital LP | 1,244,864 | $1.20M | 0.21% | +1,244,864 | New |
| Stonepine Capital Management, LLC | 622,432 | $544.9K | 0.41% | +622,432 | New |
| L1 Global Manager Pty Ltd | 248,972 | $256.4K | 0.21% | +248,972 | New |
| Morgan Stanley | 143,245 | $147.5K | 0.00% | +143,245 | New |
| Geode Capital Management, LLC | 110,477 | $113.8K | 0.00% | −12,905−10.5% | Reduced |
| Renaissance Technologies LLC | 97,300 | $100.2K | 0.00% | −30,775−24.0% | Reduced |
| Vanguard Capital Management LLC | 88,956 | $91.6K | 0.00% | −80,154−47.4% | Reduced |
Holders of 5% or more of CALC
See all 7 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of CalciMedica, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Alafi Capital Co LLC | 13D/A | 19.90%7.22M shares | +2.80 ppfrom 17.10% | Apr 1, 20254 filings | Aug 24, 2026 | SEC |
| Bering Partners II GP, L.L.C. | 13D/A | 9.99%3.55M shares | +3.09 ppfrom 6.90% | Oct 29, 20253 filings | Aug 21, 2026 | SEC |
| Armistice Capital, LLC | 13G | 9.99%3.41M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Woodline Partners LP | 13G | 8.10%2.49M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Valence Investments SPV VI, LLC | 13D/A | 6.40%1.97M shares | – | Mar 30, 20235 filings | Jun 30, 2026 | SEC |